• ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT

INVESTORS

[이투데이] 김건수 큐로셀 대표 “국산 CAR-T 상업화·흑자전환 임박” [상장 새내기 바이오①]

2024/02/20

김건수 큐로셀 대표 “국산 CAR-T 상업화·흑자전환 임박” [상장 새내기 바이오①] – 이투데이 (etoday.co.kr)

Prev[시사저널e] [바이오 줌人] 김건수 큐로셀 대표 “내년 국산 CAR-T 치료제 상용화”
Next[더바이오] 큐로셀 “계획대로 9월 CAR-T ‘안발셀’ 허가신청…조건부 아닌 정식 절차”
Copyright 2023. Curocell Inc. All Rights Reserved.
Created by PRESSCAT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
  • ABOUT US
  • SCIENCE
  • FACILITY
  • INVESTORS
    • Media
    • Notice
    • Public Disclosures
    • Stock Information
    • Financials
  • ESG
    • ESG Management
    • Archive
  • CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.